- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Generic Injectables market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Generic Injectables market size is estimated to be worth US$ 31500 million in 2021 and is forecast to a readjusted size of USD 39670 million by 2028 with a CAGR of 3.3% during review period. Oncology accounting for % of the Generic Injectables global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Small Molecule segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Generic Injectables include Hospira (Pfizer Inc.), Fresenius Kabi, Sandoz (Novartis), Hikma Pharmaceuticals PLC, and Dr. Reddy’s Laboratories Ltd, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Generic Injectables market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Small Molecule
Large Molecule
Market segment by Application, can be divided into
Oncology
Anesthesia
Anti-Infectives
Parenteral Nutrition
Cardiovascular Diseases
Market segment by players, this report covers
Hospira (Pfizer Inc.)
Fresenius Kabi
Sandoz (Novartis)
Hikma Pharmaceuticals PLC
Dr. Reddy’s Laboratories Ltd
Grifols
Nichi-Iko Group (Sagent)
Teva Pharmaceutical
Auromedics
Sanofi
Gland Pharma
Endo International PLC
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Generic Injectables product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Generic Injectables, with revenue, gross margin and global market share of Generic Injectables from 2019 to 2022.
Chapter 3, the Generic Injectables competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Generic Injectables market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Generic Injectables research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Generic Injectables
1.2 Classification of Generic Injectables by Type
1.2.1 Overview: Global Generic Injectables Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Generic Injectables Revenue Market Share by Type in 2021
1.2.3 Small Molecule
1.2.4 Large Molecule
1.3 Global Generic Injectables Market by Application
1.3.1 Overview: Global Generic Injectables Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Oncology
1.3.3 Anesthesia
1.3.4 Anti-Infectives
1.3.5 Parenteral Nutrition
1.3.6 Cardiovascular Diseases
1.4 Global Generic Injectables Market Size & Forecast
1.5 Global Generic Injectables Market Size and Forecast by Region
1.5.1 Global Generic Injectables Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Generic Injectables Market Size by Region, (2017-2022)
1.5.3 North America Generic Injectables Market Size and Prospect (2017-2028)
1.5.4 Europe Generic Injectables Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Generic Injectables Market Size and Prospect (2017-2028)
1.5.6 South America Generic Injectables Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Generic Injectables Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Generic Injectables Market Drivers
1.6.2 Generic Injectables Market Restraints
1.6.3 Generic Injectables Trends Analysis
2 Company Profiles
2.1 Hospira (Pfizer Inc.)
2.1.1 Hospira (Pfizer Inc.) Details
2.1.2 Hospira (Pfizer Inc.) Major Business
2.1.3 Hospira (Pfizer Inc.) Generic Injectables Product and Solutions
2.1.4 Hospira (Pfizer Inc.) Generic Injectables Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Hospira (Pfizer Inc.) Recent Developments and Future Plans
2.2 Fresenius Kabi
2.2.1 Fresenius Kabi Details
2.2.2 Fresenius Kabi Major Business
2.2.3 Fresenius Kabi Generic Injectables Product and Solutions
2.2.4 Fresenius Kabi Generic Injectables Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Fresenius Kabi Recent Developments and Future Plans
2.3 Sandoz (Novartis)
2.3.1 Sandoz (Novartis) Details
2.3.2 Sandoz (Novartis) Major Business
2.3.3 Sandoz (Novartis) Generic Injectables Product and Solutions
2.3.4 Sandoz (Novartis) Generic Injectables Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Sandoz (Novartis) Recent Developments and Future Plans
2.4 Hikma Pharmaceuticals PLC
2.4.1 Hikma Pharmaceuticals PLC Details
2.4.2 Hikma Pharmaceuticals PLC Major Business
2.4.3 Hikma Pharmaceuticals PLC Generic Injectables Product and Solutions
2.4.4 Hikma Pharmaceuticals PLC Generic Injectables Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Hikma Pharmaceuticals PLC Recent Developments and Future Plans
2.5 Dr. Reddy’s Laboratories Ltd
2.5.1 Dr. Reddy’s Laboratories Ltd Details
2.5.2 Dr. Reddy’s Laboratories Ltd Major Business
2.5.3 Dr. Reddy’s Laboratories Ltd Generic Injectables Product and Solutions
2.5.4 Dr. Reddy’s Laboratories Ltd Generic Injectables Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Dr. Reddy’s Laboratories Ltd Recent Developments and Future Plans
2.6 Grifols
2.6.1 Grifols Details
2.6.2 Grifols Major Business
2.6.3 Grifols Generic Injectables Product and Solutions
2.6.4 Grifols Generic Injectables Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Grifols Recent Developments and Future Plans
2.7 Nichi-Iko Group (Sagent)
2.7.1 Nichi-Iko Group (Sagent) Details
2.7.2 Nichi-Iko Group (Sagent) Major Business
2.7.3 Nichi-Iko Group (Sagent) Generic Injectables Product and Solutions
2.7.4 Nichi-Iko Group (Sagent) Generic Injectables Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Nichi-Iko Group (Sagent) Recent Developments and Future Plans
2.8 Teva Pharmaceutical
2.8.1 Teva Pharmaceutical Details
2.8.2 Teva Pharmaceutical Major Business
2.8.3 Teva Pharmaceutical Generic Injectables Product and Solutions
2.8.4 Teva Pharmaceutical Generic Injectables Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Teva Pharmaceutical Recent Developments and Future Plans
2.9 Auromedics
2.9.1 Auromedics Details
2.9.2 Auromedics Major Business
2.9.3 Auromedics Generic Injectables Product and Solutions
2.9.4 Auromedics Generic Injectables Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Auromedics Recent Developments and Future Plans
2.10 Sanofi
2.10.1 Sanofi Details
2.10.2 Sanofi Major Business
2.10.3 Sanofi Generic Injectables Product and Solutions
2.10.4 Sanofi Generic Injectables Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Sanofi Recent Developments and Future Plans
2.11 Gland Pharma
2.11.1 Gland Pharma Details
2.11.2 Gland Pharma Major Business
2.11.3 Gland Pharma Generic Injectables Product and Solutions
2.11.4 Gland Pharma Generic Injectables Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Gland Pharma Recent Developments and Future Plans
2.12 Endo International PLC
2.12.1 Endo International PLC Details
2.12.2 Endo International PLC Major Business
2.12.3 Endo International PLC Generic Injectables Product and Solutions
2.12.4 Endo International PLC Generic Injectables Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Endo International PLC Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Generic Injectables Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Generic Injectables Players Market Share in 2021
3.2.2 Top 10 Generic Injectables Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Generic Injectables Players Head Office, Products and Services Provided
3.4 Generic Injectables Mergers & Acquisitions
3.5 Generic Injectables New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Generic Injectables Revenue and Market Share by Type (2017-2022)
4.2 Global Generic Injectables Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Generic Injectables Revenue Market Share by Application (2017-2022)
5.2 Global Generic Injectables Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Generic Injectables Revenue by Type (2017-2028)
6.2 North America Generic Injectables Revenue by Application (2017-2028)
6.3 North America Generic Injectables Market Size by Country
6.3.1 North America Generic Injectables Revenue by Country (2017-2028)
6.3.2 United States Generic Injectables Market Size and Forecast (2017-2028)
6.3.3 Canada Generic Injectables Market Size and Forecast (2017-2028)
6.3.4 Mexico Generic Injectables Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Generic Injectables Revenue by Type (2017-2028)
7.2 Europe Generic Injectables Revenue by Application (2017-2028)
7.3 Europe Generic Injectables Market Size by Country
7.3.1 Europe Generic Injectables Revenue by Country (2017-2028)
7.3.2 Germany Generic Injectables Market Size and Forecast (2017-2028)
7.3.3 France Generic Injectables Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Generic Injectables Market Size and Forecast (2017-2028)
7.3.5 Russia Generic Injectables Market Size and Forecast (2017-2028)
7.3.6 Italy Generic Injectables Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Generic Injectables Revenue by Type (2017-2028)
8.2 Asia-Pacific Generic Injectables Revenue by Application (2017-2028)
8.3 Asia-Pacific Generic Injectables Market Size by Region
8.3.1 Asia-Pacific Generic Injectables Revenue by Region (2017-2028)
8.3.2 China Generic Injectables Market Size and Forecast (2017-2028)
8.3.3 Japan Generic Injectables Market Size and Forecast (2017-2028)
8.3.4 South Korea Generic Injectables Market Size and Forecast (2017-2028)
8.3.5 India Generic Injectables Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Generic Injectables Market Size and Forecast (2017-2028)
8.3.7 Australia Generic Injectables Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Generic Injectables Revenue by Type (2017-2028)
9.2 South America Generic Injectables Revenue by Application (2017-2028)
9.3 South America Generic Injectables Market Size by Country
9.3.1 South America Generic Injectables Revenue by Country (2017-2028)
9.3.2 Brazil Generic Injectables Market Size and Forecast (2017-2028)
9.3.3 Argentina Generic Injectables Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Generic Injectables Revenue by Type (2017-2028)
10.2 Middle East & Africa Generic Injectables Revenue by Application (2017-2028)
10.3 Middle East & Africa Generic Injectables Market Size by Country
10.3.1 Middle East & Africa Generic Injectables Revenue by Country (2017-2028)
10.3.2 Turkey Generic Injectables Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Generic Injectables Market Size and Forecast (2017-2028)
10.3.4 UAE Generic Injectables Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Generic Injectables Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Generic Injectables Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Generic Injectables Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Generic Injectables Revenue (USD Million) by Region (2017-2022)
Table 5. Global Generic Injectables Revenue Market Share by Region (2023-2028)
Table 6. Hospira (Pfizer Inc.) Corporate Information, Head Office, and Major Competitors
Table 7. Hospira (Pfizer Inc.) Major Business
Table 8. Hospira (Pfizer Inc.) Generic Injectables Product and Solutions
Table 9. Hospira (Pfizer Inc.) Generic Injectables Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Fresenius Kabi Corporate Information, Head Office, and Major Competitors
Table 11. Fresenius Kabi Major Business
Table 12. Fresenius Kabi Generic Injectables Product and Solutions
Table 13. Fresenius Kabi Generic Injectables Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Sandoz (Novartis) Corporate Information, Head Office, and Major Competitors
Table 15. Sandoz (Novartis) Major Business
Table 16. Sandoz (Novartis) Generic Injectables Product and Solutions
Table 17. Sandoz (Novartis) Generic Injectables Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Hikma Pharmaceuticals PLC Corporate Information, Head Office, and Major Competitors
Table 19. Hikma Pharmaceuticals PLC Major Business
Table 20. Hikma Pharmaceuticals PLC Generic Injectables Product and Solutions
Table 21. Hikma Pharmaceuticals PLC Generic Injectables Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Dr. Reddy’s Laboratories Ltd Corporate Information, Head Office, and Major Competitors
Table 23. Dr. Reddy’s Laboratories Ltd Major Business
Table 24. Dr. Reddy’s Laboratories Ltd Generic Injectables Product and Solutions
Table 25. Dr. Reddy’s Laboratories Ltd Generic Injectables Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Grifols Corporate Information, Head Office, and Major Competitors
Table 27. Grifols Major Business
Table 28. Grifols Generic Injectables Product and Solutions
Table 29. Grifols Generic Injectables Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Nichi-Iko Group (Sagent) Corporate Information, Head Office, and Major Competitors
Table 31. Nichi-Iko Group (Sagent) Major Business
Table 32. Nichi-Iko Group (Sagent) Generic Injectables Product and Solutions
Table 33. Nichi-Iko Group (Sagent) Generic Injectables Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Teva Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 35. Teva Pharmaceutical Major Business
Table 36. Teva Pharmaceutical Generic Injectables Product and Solutions
Table 37. Teva Pharmaceutical Generic Injectables Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Auromedics Corporate Information, Head Office, and Major Competitors
Table 39. Auromedics Major Business
Table 40. Auromedics Generic Injectables Product and Solutions
Table 41. Auromedics Generic Injectables Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Sanofi Corporate Information, Head Office, and Major Competitors
Table 43. Sanofi Major Business
Table 44. Sanofi Generic Injectables Product and Solutions
Table 45. Sanofi Generic Injectables Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Gland Pharma Corporate Information, Head Office, and Major Competitors
Table 47. Gland Pharma Major Business
Table 48. Gland Pharma Generic Injectables Product and Solutions
Table 49. Gland Pharma Generic Injectables Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Endo International PLC Corporate Information, Head Office, and Major Competitors
Table 51. Endo International PLC Major Business
Table 52. Endo International PLC Generic Injectables Product and Solutions
Table 53. Endo International PLC Generic Injectables Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Global Generic Injectables Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 55. Global Generic Injectables Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 56. Breakdown of Generic Injectables by Company Type (Tier 1, Tier 2 and Tier 3)
Table 57. Generic Injectables Players Head Office, Products and Services Provided
Table 58. Generic Injectables Mergers & Acquisitions in the Past Five Years
Table 59. Generic Injectables New Entrants and Expansion Plans
Table 60. Global Generic Injectables Revenue (USD Million) by Type (2017-2022)
Table 61. Global Generic Injectables Revenue Share by Type (2017-2022)
Table 62. Global Generic Injectables Revenue Forecast by Type (2023-2028)
Table 63. Global Generic Injectables Revenue by Application (2017-2022)
Table 64. Global Generic Injectables Revenue Forecast by Application (2023-2028)
Table 65. North America Generic Injectables Revenue by Type (2017-2022) & (USD Million)
Table 66. North America Generic Injectables Revenue by Type (2023-2028) & (USD Million)
Table 67. North America Generic Injectables Revenue by Application (2017-2022) & (USD Million)
Table 68. North America Generic Injectables Revenue by Application (2023-2028) & (USD Million)
Table 69. North America Generic Injectables Revenue by Country (2017-2022) & (USD Million)
Table 70. North America Generic Injectables Revenue by Country (2023-2028) & (USD Million)
Table 71. Europe Generic Injectables Revenue by Type (2017-2022) & (USD Million)
Table 72. Europe Generic Injectables Revenue by Type (2023-2028) & (USD Million)
Table 73. Europe Generic Injectables Revenue by Application (2017-2022) & (USD Million)
Table 74. Europe Generic Injectables Revenue by Application (2023-2028) & (USD Million)
Table 75. Europe Generic Injectables Revenue by Country (2017-2022) & (USD Million)
Table 76. Europe Generic Injectables Revenue by Country (2023-2028) & (USD Million)
Table 77. Asia-Pacific Generic Injectables Revenue by Type (2017-2022) & (USD Million)
Table 78. Asia-Pacific Generic Injectables Revenue by Type (2023-2028) & (USD Million)
Table 79. Asia-Pacific Generic Injectables Revenue by Application (2017-2022) & (USD Million)
Table 80. Asia-Pacific Generic Injectables Revenue by Application (2023-2028) & (USD Million)
Table 81. Asia-Pacific Generic Injectables Revenue by Region (2017-2022) & (USD Million)
Table 82. Asia-Pacific Generic Injectables Revenue by Region (2023-2028) & (USD Million)
Table 83. South America Generic Injectables Revenue by Type (2017-2022) & (USD Million)
Table 84. South America Generic Injectables Revenue by Type (2023-2028) & (USD Million)
Table 85. South America Generic Injectables Revenue by Application (2017-2022) & (USD Million)
Table 86. South America Generic Injectables Revenue by Application (2023-2028) & (USD Million)
Table 87. South America Generic Injectables Revenue by Country (2017-2022) & (USD Million)
Table 88. South America Generic Injectables Revenue by Country (2023-2028) & (USD Million)
Table 89. Middle East & Africa Generic Injectables Revenue by Type (2017-2022) & (USD Million)
Table 90. Middle East & Africa Generic Injectables Revenue by Type (2023-2028) & (USD Million)
Table 91. Middle East & Africa Generic Injectables Revenue by Application (2017-2022) & (USD Million)
Table 92. Middle East & Africa Generic Injectables Revenue by Application (2023-2028) & (USD Million)
Table 93. Middle East & Africa Generic Injectables Revenue by Country (2017-2022) & (USD Million)
Table 94. Middle East & Africa Generic Injectables Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Generic Injectables Picture
Figure 2. Global Generic Injectables Revenue Market Share by Type in 2021
Figure 3. Small Molecule
Figure 4. Large Molecule
Figure 5. Generic Injectables Revenue Market Share by Application in 2021
Figure 6. Oncology Picture
Figure 7. Anesthesia Picture
Figure 8. Anti-Infectives Picture
Figure 9. Parenteral Nutrition Picture
Figure 10. Cardiovascular Diseases Picture
Figure 11. Global Generic Injectables Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Generic Injectables Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Generic Injectables Revenue Market Share by Region (2017-2028)
Figure 14. Global Generic Injectables Revenue Market Share by Region in 2021
Figure 15. North America Generic Injectables Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Generic Injectables Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Generic Injectables Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Generic Injectables Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Generic Injectables Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Generic Injectables Market Drivers
Figure 21. Generic Injectables Market Restraints
Figure 22. Generic Injectables Market Trends
Figure 23. Hospira (Pfizer Inc.) Recent Developments and Future Plans
Figure 24. Fresenius Kabi Recent Developments and Future Plans
Figure 25. Sandoz (Novartis) Recent Developments and Future Plans
Figure 26. Hikma Pharmaceuticals PLC Recent Developments and Future Plans
Figure 27. Dr. Reddy’s Laboratories Ltd Recent Developments and Future Plans
Figure 28. Grifols Recent Developments and Future Plans
Figure 29. Nichi-Iko Group (Sagent) Recent Developments and Future Plans
Figure 30. Teva Pharmaceutical Recent Developments and Future Plans
Figure 31. Auromedics Recent Developments and Future Plans
Figure 32. Sanofi Recent Developments and Future Plans
Figure 33. Gland Pharma Recent Developments and Future Plans
Figure 34. Endo International PLC Recent Developments and Future Plans
Figure 35. Global Generic Injectables Revenue Share by Players in 2021
Figure 36. Generic Injectables Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 37. Global Top 3 Players Generic Injectables Revenue Market Share in 2021
Figure 38. Global Top 10 Players Generic Injectables Revenue Market Share in 2021
Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 40. Global Generic Injectables Revenue Share by Type in 2021
Figure 41. Global Generic Injectables Market Share Forecast by Type (2023-2028)
Figure 42. Global Generic Injectables Revenue Share by Application in 2021
Figure 43. Global Generic Injectables Market Share Forecast by Application (2023-2028)
Figure 44. North America Generic Injectables Sales Market Share by Type (2017-2028)
Figure 45. North America Generic Injectables Sales Market Share by Application (2017-2028)
Figure 46. North America Generic Injectables Revenue Market Share by Country (2017-2028)
Figure 47. United States Generic Injectables Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Canada Generic Injectables Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Mexico Generic Injectables Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Europe Generic Injectables Sales Market Share by Type (2017-2028)
Figure 51. Europe Generic Injectables Sales Market Share by Application (2017-2028)
Figure 52. Europe Generic Injectables Revenue Market Share by Country (2017-2028)
Figure 53. Germany Generic Injectables Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. France Generic Injectables Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. United Kingdom Generic Injectables Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Russia Generic Injectables Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Italy Generic Injectables Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Asia-Pacific Generic Injectables Sales Market Share by Type (2017-2028)
Figure 59. Asia-Pacific Generic Injectables Sales Market Share by Application (2017-2028)
Figure 60. Asia-Pacific Generic Injectables Revenue Market Share by Region (2017-2028)
Figure 61. China Generic Injectables Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Japan Generic Injectables Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South Korea Generic Injectables Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. India Generic Injectables Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Southeast Asia Generic Injectables Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Australia Generic Injectables Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South America Generic Injectables Sales Market Share by Type (2017-2028)
Figure 68. South America Generic Injectables Sales Market Share by Application (2017-2028)
Figure 69. South America Generic Injectables Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Generic Injectables Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Generic Injectables Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East and Africa Generic Injectables Sales Market Share by Type (2017-2028)
Figure 73. Middle East and Africa Generic Injectables Sales Market Share by Application (2017-2028)
Figure 74. Middle East and Africa Generic Injectables Revenue Market Share by Country (2017-2028)
Figure 75. Turkey Generic Injectables Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Generic Injectables Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. UAE Generic Injectables Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Methodology
Figure 79. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
